Drugs / Freeze-dried Human Rabies Vaccine (Vero Cell)
Freeze-dried Human Rabies Vaccine (Vero Cell)
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT05549908 | Jul 2020 → Oct 2021 | rabies | Changchun Zhuoyi Biological Co., Ltd | Completed | Met primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT05547815 | Nov 2019 → Dec 2020 | rabies | Changchun Zhuoyi Biological Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | freeze-dried human rabies vaccine (Vero cell) | “Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell)” NCT05547815 ↗1“freeze-dried human rabies vaccine (Vero cell) inoculated in 4-dose program (2-1-1)” NCT05549908 ↗ |
| Modality | Vaccine | “Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell)” NCT05547815 ↗ |